Claudication with Multilevel Peripheral Artery Disease
A 66-year-old man with type 2 diabetes, hypertension, and a 40-pack-year smoking history reports lifestyle-limiting claudication after 100 meters, now limiting his ability to work. He has no rest pain or tissue loss. Ankle-brachial index is 0.62 on the right and 0.85 on the left. Duplex ultrasound shows a long superficial femoral artery occlusion and a focal stenosis in the right common iliac artery. He is on aspirin, a statin, and metformin; his blood pressure is 148/88 mmHg and he still smokes. He asks whether stenting or surgery is better and whether he can avoid intervention.
1. What is your initial management, and when would you intervene?
Read the worked answer
Initial management is guideline-directed medical therapy and supervised exercise for claudication without limb threat:
- Smoking cessation is the single most important intervention; offer pharmacotherapy and counseling.
- Antiplatelet therapy (aspirin or clopidogrel) and high-intensity statin.
- Blood pressure control to <130/80 mmHg; ACE inhibitor or ARB preferred in diabetes.
- Diabetes control with HbA1c target individualized.
- Supervised exercise therapy (30–45 min, 3–5 times/week) improves walking distance and quality of life.
Intervention is indicated for lifestyle-limiting symptoms that persist despite medical and exercise therapy, or for limb threat (rest pain, tissue loss). Since he has lifestyle-limiting claudication affecting work, he is a candidate for revascularization if conservative measures fail or if symptoms are severe enough to justify it now.
2. If revascularization is chosen, what approach would you take for his multilevel disease?
Read the worked answer
He has multilevel disease: a focal common iliac stenosis and a long SFA occlusion. Principles:
- Treat inflow first (iliac lesion) before outflow, because iliac revascularization improves inflow and may improve symptoms even before SFA treatment.
- Iliac stenosis: endovascular stenting (balloon-expandable covered or bare-metal stent) is first-line for focal common iliac disease, with good patency.
- Long SFA occlusion: endovascular options include drug-coated balloon angioplasty with bailout stenting, or covered stents; surgical bypass (femoral-popliteal) is an option for long occlusions with good conduit and expected durability, especially in a patient with diabetes and a long lesion.
- Hybrid approach may be appropriate: iliac stenting plus surgical or endovascular SFA treatment.
- Decision factors: lesion length, calcification, availability of vein conduit, patient preference, and expected durability. For a long SFA occlusion, bypass with autologous vein has better long-term patency than endovascular therapy, but endovascular is less invasive.
3. What would you tell him about the role of his smoking and diabetes in outcomes?
Read the worked answer
- Smoking is the strongest modifiable risk factor for PAD progression, restenosis, and cardiovascular events. Continued smoking increases the risk of bypass graft failure and stent restenosis. Cessation should be emphasized at every visit.
- Diabetes increases the risk of restenosis and microvascular complications; glycemic control and foot care are essential.
- Secondary prevention (antiplatelet, statin, BP control) reduces MI and stroke risk independent of claudication symptoms.
- Realistic expectations: revascularization improves symptoms but does not cure PAD; lifestyle modification and medical therapy are lifelong.